Aortic Stiffness in Hypertrophic Cardiomyopathy  by O'Rourke, Michael F. et al.
c
i
t
n
a
d
W
p
l
P
l
m
n
O
t
S
s
v
v
p
u
c
p
c
r
U
p
k
d
m
H
a
P
s
w
t
p
d
t
t
*
A
B
*
N
C
T
1
N
E
R
1
2
3
4
5
6
7
A
H
I
J
(
c
n
o
B
d
e
r
fi
v
s
t
o
n
6
H
s
w
f
u
9
a
n
“
2
o
t
504 Correspondence JACC Vol. 55, No. 5, 2010
February 2, 2010:499–506olleagues remain concerned that we have underestimated the
mportance of PMI. We agree with many of the suppositions in
heir communication (as clearly stated throughout our report [1]),
amely that “even small periprocedural troponin rises reflect new
reas of myocardial necrosis on MRI imaging,” and “there is little
oubt about the influence of large periprocedural enzyme rises . . . .”
e disagree, however, that “debate persists about the influence on
rognosis of these small/moderate enzyme rises . . . .” Whereas the
iterature is replete with prior studies examining the influence of
MI, the largest studies in the stent era have shown that only truly
arge PMI as evidenced by elevation of peak creatine kinase-
yocardial band to 8 or 10 normal or the development of
ew Q-waves significantly influences subsequent survival (2,3).
ther studies that have used a low threshold for PMI have found
hat such infarctions have no long-term prognostic significance (4).
maller enzyme elevations are a marker for more diffuse athero-
clerosis (5), but do not have per se a great enough influence on left
entricular function or arrhythmogenesis to directly impair sur-
ival. Other studies have suggested that biomarker elevations after
ercutaneous coronary intervention are of no clinical relevance
nless associated with a failed procedure or angiographic compli-
ations (6). We also agree with Dr. Lim and colleagues that the
rognostic implications of troponin elevations after percutaneous
oronary intervention are uncertain, with questionable clinical
elevance (7).
The data from the ACUITY (Acute Catheterization and
rgent Intervention Triage Strategy) trial are consistent with these
revious studies; when considering all PMI (defined as creatine
inase-myocardial band 3 normal, the most widely used
efinition) in a time-updated, covariate-adjusted multivariable
odel, PMI was not an independent correlate of 1-year survival.
owever, large PMI (such as Q-wave myocardial infarction), was
predictor. Our study was not meant to minimize the role of large
MI, which clearly reduce early and late survival. Rather, most
mall PMI may be disregarded as clinically inconsequential,
hereas SMI, even using a sensitive threshold for detection (any
roponin elevation greater than the local laboratory normal), is a
owerful independent predictor of subsequent mortality. These
ata emphasize the fact that SMI and PMI deserve different
hresholds for diagnosis and should prompt suitably different
herapeutic responses.
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ortic Stiffness in
ypertrophic Cardiomyopathy
n the paper by Boonyasirinant et al. (1) in a recent issue of the
ournal, there are serious problems in the use of pulse wave velocity
PWV) data as an index of aortic stiffness in hypertrophic
ardiomyopathy (HCM).
The major technical problem is that whereas magnetic reso-
ance imaging (MRI) can measure dimensions accurately, it can
nly measure flow at intervals of around 30 ms (Fig. 1 from
oonyasirinant et al. [1]), so that PWV, as distance travelled
ivided by time between wave feet, is likely to be less accurate,
specially over very short distances (typically 12 to 13 cm in this
eport [1]) than when measured invasively or noninvasively by high
delity manometry (2,3). This may account for unusually high
ariability of PWV measurements, especially in the HCM groups.
The most curious issue in this MRI report (1) is that normal
ubjects had lower values of aortic PWV (3.7 m/s, SD 0.9 m/s)
han previously published for any normal group using invasive
r noninvasive techniques (2,3). A previous MRI study (4) in
ormal (but obese) subjects of similar age gave PWV values of
.8 m/s (SD 2.2 m/s), which is similar to that reported for
CM patients in the recent MRI report (1). Further, normal
ubjects (Fig. 5 from Boonyasirinant et al. [1]) had a blunted
ave foot for the distal aortic wave, which is quite different
rom normal flow and pressure waves, from which PWV is
sually calculated. High variability of PWV in HCM (mean
.66 m/s, SD 6.43 m/s in 1 group and 6.51 m/s, SD 3.2 m/s in
nother) is not correctly represented in Figure 2 of Boonyasiri-
ant et al. (1), nor are the confidence intervals, whose long
whiskers” do not appear at all. Data in the text and legend of Figure
(1) do not correspond to that shown in the figure.
These issues ought to be considered before the confident assertions
f Boonyasirinant et al. (1) or Kuhl (5) are accepted that the MRI
echnique reveals “novel insights in vascular function from MRI” (1)
r “an unidentified association unraveled by MRI” (5).
*
T
A
*
4
D
N
A
E
P
m
R
1
2
3
4
5
I
H
D
W
T
a
d
c
w
t
a
d
m
w
s
i
c
p
s
s
e
p
a
a
w
e
M
p
*
M
T
*
M
U
H
P
K
H
E
R
1
2
3
R
W
c
t
s
v
w
a
s
w
a
2
P
t
d
a
505JACC Vol. 55, No. 5, 2010 Correspondence
February 2, 2010:499–506Michael F. O’Rourke, MD, DSc
homas Weber, MD
udrey Adji, MB, MBiomedE
St. Vincent’s Clinic
38 Victoria Street, Suite 810
arlinghurst, Sydney
SW 2010
ustralia
-mail: m.orourke@unsw.edu.au
doi:10.1016/j.jacc.2009.08.066
lease note: Dr. O’Rourke is a founding director of AtCor Medical Pty. Ltd.,
anufacturer of systems for analyzing arterial pulse.
EFERENCES
. Boonyasirinant T, Rajiah P, Setser RM, et al. Aortic stiffness is
increased in hypertrophic cardiomyopathy with myocardial fibrosis:
novel insights in vascular function from magnetic resonance imaging.
J Am Coll Cardiol 2009;54:255–62.
. Weber T, Ammer M, Rammer M, et al. Noninvasive determination of
carotid-femoral pulse wave velocity depends critically on assessment of
travel distance: a comparison with invasive measurement. J Hypertens
2009;27:1624–30.
. Laurent S, Cockcroft J, Van Bortel L, et al., on behalf of the European
Network for Noninvasive Investigation of Large Arteries. Expert
consensus document on arterial stiffness: methodological issues and
clinical applications. Eur Heart J 2006;27:2588–605.
. Joly L, Perret-Guillaume C, Kearney-Schwartz A, et al. Pulse wave velocity
assessment by external non-invasive devices and phase-contrast magnetic
resonance imaging in the obese. Hypertension 2009;54:421–506.
. Kuhl HP. Hypertrophic cardiomyopathy, fibrosis, and aortic stiffness:
an unidentified association unraveled by magnetic resonance imaging.
J Am Coll Cardiol 2009;54:263–4.
ncreased Aortic Stiffness in
ypertrophic Cardiomyopathy
ifferent Methods, Same Conclusions?
e read the report by Boonyasirinant et al. (1) with great interest.
he major finding of this study was that increased aortic stiffness,
s indicated by increased magnetic resonance imaging (MRI)-
erived pulse wave velocity (PWV), is evident in hypertrophic
ardiomyopathy (HCM) patients and is more pronounced in those
ith myocardial fibrosis. The results are impressive, but we feel
hat a few additional comments are necessary.
Boonyasirinant et al. (1) used MRI-PWV analysis to quantify
ortic stiffness in their clinical study. Measurement of PWV by
ifferent tonometric, piezoelectronic, oscillometric, and MRI
ethods are widely used scientific tools. However, there is another
ay to evaluate aortic stiffness, for which 2 important variables
hould be noted: 1) the change in volume due to blood injection
nto the aorta; and 2) the pressure change caused by this volume
hange (2). Together with measurement of forearm systolic blood
ressure (SBP) and diastolic blood pressure (DBP) changes, aortic
ystolic diameter (SD) and diastolic diameter (DD) or cross-
ectional areas at different levels of aorta can be measured with
chocardiography, computed tomography, or MRI. Using these
arameters, indexes or moduli can be calculated characterizing
ortic elasticity (3). The most important parameters are listed here: t• Aortic strain  (SD – DD)/DD
• Aortic stiffness index (beta)  ln (SBP/DBP)/[(SD – DD)/
DD], where SBP and DBP are the systolic and diastolic
blood pressures, and ln is the natural logarithm
• Aortic distensibility 2 (SD – DD)/[(SBP – DBP)DD]
• Aortic elastic modulus E(p)  (SBP – DBP)/[(SD – DD)/
DD]
• Young’s circumferential static elastic modulus E(s)  E(p) 
DD/2h, where h indicates diastolic intima-media thickness
Boonyasirinant et al. (1) were the first to demonstrate alterations in
ortic distensibility in HCM. However, further investigations are
arranted to examine the previously mentioned parameters in HCM,
specially with versus without left ventricular outflow gradients.
oreover, correlations between PWV and echocardiography-derived
arameters should be confirmed in HCM as well.
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e thank Dr. O’Rourke and colleagues and Dr. Nemes and
olleagues for the interest in our study (1). A common thread is
hat each promotes alternative methods for computing aortic
tiffness to the method we chose to employ, namely pulse wave
elocity (PWV) computed by magnetic resonance imaging (MRI).
We are in agreement with Dr. Nemes and colleagues that more
ork is needed between and among these various approaches. We
lso recognize that many techniques exist to quantify aortic
tiffness, and each is subject to its own characteristic strengths and
eaknesses. Reliable quantification of PWV is dependent on
ccurate measurement of both the aortic flow (or pressure) wave at
measurement sites as well as the distance between these 2 sites.
reviously, in numerous studies, MRI has been shown as a reliable
echnique for quantifying the aortic flow wave; its longitudinal
imensional accuracy is unparalleled, although it does suffer from
relatively low temporal resolution when compared with alternate
echniques.
